Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,456,834
New position
Shares Held
369,740
first reported quarter
Ownership
0.179%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#57
of 332 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Meridiem Capital Partners LP holds $354,215,795 across 10 Diagnostics & Research names. QGEN ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
537,437 | $102,370,999 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
50,157 | $64,076,069 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
246,979 | $56,012,367 | |
| 4 | WAT |
Waters Corp /De/
|
99,260 | $37,226,470 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
144,630 | $27,945,408 | |
| 6 | RVTY |
Revvity, Inc.
|
193,094 | $21,483,638 | |
| 7 | GH |
Guardant Health, Inc.
|
97,088 | $14,566,112 | |
| 8 | QGEN |
Qiagen N.V.
This page
|
369,740 | $14,456,834 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,456,834 | 369,740 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||